Searching journal content for articles similar to Araki et al. 23 (11): 857.

Displaying results 1-10 of 91
For checked items
  1. ...Copy number variations of E2F1 : a new genetic risk factor for testicular cancer Maria Santa Rocca 1 , Andrea Di Nisio 1 , Arianna Marchiori 1 , Marco Ghezzi 1 , Giuseppe Opocher 1, 2 , Carlo Foresta 1 and Alberto Ferlin 1 ⇑ 1 Department of Medicine , DIMED University of Padua, Padua, Italy 2...
  2. ...syndrome. Reviews in Endocrine and Metabolic Disorders 11 117–126. (doi:10.1007/s11154-010-9139-z) Araki T, Liu N-A, Tone Y, Cuevas-Ramos D, Heltsley R, Tone M & Melmed S 2016 E2F1-mediated human POMC expression in ectopic Cushing’s syndrome. Endocrine-Related Cancer 23 857–870. (doi:10.1530/ERC-16...
  3. ...between PIT1 and(Correspondence should be addressed to A Fusco; Email: [email protected]) Abstract We have previously demonstrated that HMGA1B and HMGA2 overexpression in mice induces the development of GH and prolactin (PRL) pituitary adenomas mainly by increasing E2F1 transcriptional activity...
  4. .../transcription factor E2F1 pathway in the growth response to P4. If extrapolated to humans, and given the importance of endogenous P4 and synthetic progestins in female reproductive functions and their pharmacotherapy, it is relevant to revisit the potential role of these hormones in the origin and growth...
  5. ...to an increased E2F1 activity, directly consequent to the HMGA2Gaetano Lombardi , Alfredo Fusco and Monica Fedele 1Dipartimento di Biologia e Patologia Cellulare e Molecolare and Istituto di Endocrinologia ed Oncologia Sperimentale del CNR, University of Naples ‘Federico II’, via Pansini 5, 80131 Naples, Italy 2...
  6. ...cross-sectional imaging (computerised tomography, CT) with a sensitivity and specificity of Table 2 Ectopic Cushing’s syndrome (CS): differences in clinical, laboratory and radiological features compared to eutopic secretion. Syndrome Mediator Tumour Clinical/biochemical Endocrine testing Radiological...
  7. ...of the proopiomelanocortin (POMC) promoter (Liu et  al. 2011). These animals (Tg: Pomc-Pttg) develop corticotroph adenomas associated with decreased glucocorticoid sensitivity, oversecretion of the corticotroph hormone (ACTH) and subsequent metabolic disturbances similar to the hyportisolism seen in Cushing’s disease...
  8. ...showed a synergistic effect only in AtT-20 cells (Fig. 5E and F). Discussion GPR101 has been previously shown to be expressed in hypothalamic neurons expressing proopiomelanocortin (POMC), the precursor of ACTH (Nilaweera et  al. 2007, Bagnol 2010). Moreover, GPR101 was shown to mediate...
  9. ...not express AR, estrogen receptor (ER), PSA (NPEPPS), PAP (REG3b), or keratin but express NSE, epithelial membrane antigen, and carcinoembryonic antigen (van Haaften-Day et al. 1987, Jelbart et al. 1989). These tumors also secrete a number of proopiomelanocortin (POMC)-derived hormones in vivo, including...
  10. ...syndrome resulting from primary thymic or bronchial NET is rare. Adrenocorticotropic hormone (ACTH) secreting and growth hormone­releasing hormone (GHRH) secreting thymic tumors have been reported in MEN1 patients resulting in ectopic Cushing’s syndrome and acromegaly, respectively (Boix et al. 2002...
For checked items